People: Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

4.32USD
4:00pm EDT
Price Change (% chg)

$0.02 (+0.47%)
Prev Close
$4.30
Open
$4.34
Day's High
$4.41
Day's Low
$4.31
Volume
459,642
Avg. Vol
1,041,065
52-wk High
$6.95
52-wk Low
$2.24

Search Stocks

Hahn, Timothy 

Brief Biography

Dr. Timothy J. Hahn Ph.D., is Senior Vice President - Manufacturing and Process Development of Novavax Inc., since June 28, 2011.Prior to joining the Company, Dr. Hahn was Vice President of Antibody Manufacturing and later Vice President of Vaccine Manufacturing at MedImmune, LLC, with responsibilities for both U.S. and non-U.S. manufacturing sites. Dr. Hahn spent more than 15 years in vaccine manufacturing with Merck & Co.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
384,426 -- 156,359 540,785

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Young

--

Stanley Erck

1,595,310

Barclay Phillips

481,646

Gregory Glenn

665,897

Sven Andreasson

--

Timothy Hahn

540,785
As Of 30 Dec 2013
Search Stocks